Allianz Asset Management Gmb H Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Allianz Asset Management Gmb H

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$144.95 - $152.29 $7.44 Million - $7.81 Million	-51,300 Reduced 21.82%	183,768 $27.8 Million
Q2 2022 Aug 12, 2022	BUY	$83.14 - $145.99 $13.5 Million - $23.8 Million	162,825 Added 225.39%	235,068 $34.3 Million
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $1,100 - $1,429	10 Added 0.01%	72,243 $8.57 Million
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $1.71 Million - $2.54 Million	-17,117 Reduced 19.16%	72,233 $9.96 Million
Q3 2021 Nov 10, 2021	BUY	$98.85 - $138.91 $4.13 Million - $5.8 Million	41,748 Added 87.7%	89,350 $12.4 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $1.1 Million - $1.75 Million	16,663 Added 53.86%	47,602 $4.62 Million
Q1 2021 May 13, 2021	BUY	$64.07 - $91.75 $447,016 - $640,139	6,977 Added 29.12%	30,939 $2.11 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $1.56 Million - $2.35 Million	23,962 New	23,962 $2.05 Million
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $242,638 - $505,297	-8,820 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$40.86 - $57.65 $206,915 - $291,939	-5,064 Reduced 36.47%	8,820 $481,000
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $2.18 Million - $2.88 Million	-58,230 Reduced 80.75%	13,884 $579,000
Q2 2019 Aug 08, 2019	BUY	$39.79 - $67.01 $459,972 - $774,635	11,560 Added 19.09%	72,114 $3.16 Million
Q1 2019 May 13, 2019	SELL	$34.52 - $53.29 $16,189 - $24,993	-469 Reduced 0.77%	60,554 $3.12 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $1.82 Million - $2.62 Million	61,023 New	61,023 $2.26 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.